< Major Announcements After Market Close >
◆ Alteogen = Signed clinical and sales license agreement for ALT-L9 with Altos Biologics
◆ Baekgeum T&A = Exchange requests disclosure regarding significant market fluctuations
◆ Yujin Enterprise = Termination of supply contract worth 110.7 billion KRW
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
